| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 May 2026 | 6 May 2026 |
| Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial Results (Standalone and Consoldiated) for the quarter and financial year ended 31 March, 2026. Outcome of the Board Meeting (As Per BSE Annoncement Dated on:13.05.2026) | ||
| Board Meeting | 6 Mar 2026 | 6 Mar 2026 |
| Outcome of the Meeting of Board of Directors | ||
| Board Meeting | 29 Jan 2026 | 22 Jan 2026 |
| Quarterly Results Outcome of the Meeting of Board of Directors (As Per BSE Announcement Dated on:29.01.2026) | ||
| Board Meeting | 11 Nov 2025 | 3 Nov 2025 |
| Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half-year ended September 30 2025 and related matters Un-audited standalone and Consolidated Financial Results for quarter and half-year ended 30th September 2025 (As Per BSE Announcement Dated on: 11/11/2025) | ||
| Board Meeting | 13 Aug 2025 | 5 Aug 2025 |
| Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2025 and related matters Financial Results Q1 FY 2025-26 (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 16 Jul 2025 | 16 Jul 2025 |
| Allotment of 91,86,490 Equity Shares of the Company on preferential basis upon conversion 91,86,490 fully paid warrants | ||
| Board Meeting | 3 Jul 2025 | 3 Jul 2025 |
| The Board of Directors of the Company in its meeting held today i.e. 03rd July, 2025 has allotted convertible Warrants to 23 allottees. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
